DrugsNews.net

Drugs Xagena

Xagena Mappa
Xagena Newsletter
OncologiaMedica.net
Pneumobase.it

Pfizer has informed Healthcare Professional of updated prescribing advice for Atorvastatin ( Lipitor ). The new advice relates to interactions and the risk of haemorrhagic stroke in patients with rece ...


The treatment of patients with diabetes mellitus should be based, wherever possible, on the results of studies of substantial size and duration that measure outcomes that are meaningful to patients. ...


Long-term use of glitazones, oral diabetic drugs, doubles the risk of fractures in women with type 2 diabetes. The findings are published in the Canadian Medical Association Journal ( CMAJ ). In abso ...


Physicians should not be prescribing antibiotics to adults for the common rhinosinusitis infection, even if patients report symptoms lasting longer than 7-10 days. Upper respiratory tract infection ...


Nearly every child who receives an antipsychotic drug is first prescribed one of the second-generation, or atypical drugs, such as Olanzapine ( Zyprexa ) and Risperidone ( Risperdal ). However, there ...


A review of studies has concluded that, compared to older drugs for Parkinson disease, a newer class of medications called dopamine agonists might be better at preventing some of the disabling muscle ...


Anticholinergic drugs may cause older people to experience greater decline in their thinking skills than people not taking the drugs, according to research presented at the American Academy of Neurolo ...


A new pilot study by Researchers at Memorial Sloan-Kettering Cancer Center ( MSKCC ) found that breast cancer patients can be treated safely with a dose-dense regimen of standard chemotherapy agents a ...


On 18 March 2009, Bristol-Myers Squibb Pharma EEIG officially notified the Committee for Medicinal Products for Human Use ( CHMP ) that it wishes to withdraw its application for a marketing authorisat ...


Denosumab ( Prolia ) is a monoclonal antibody against receptor activator of nuclear factor-kappa B ligand ( RANKL ).The following safety issues associated with Denosumab exposure have been identified ...


The FDA ( Food and Drug Administration ) issued new information to health care professionals to alert them about an increased risk of suicidal thoughts and behaviors in patients who take drugs called ...


Tumor necrosis factor a ( TNF- alpha ) blockade has emerged as a useful therapy for collagen vascular diseases or graft-vs-host disease. Fungal infections complicating such therapy have been reported ...


The FDA ( Food and Drug Administration ) has approved Nexium ( Esomeprazole ) for short-term use in children ages 1-11 years for the treatment of gastroesophageal reflux disease ( GERD ). The agency ...


Biogen ldec and Elan have informed HealthCare Profesionals of new safety information regarding Tysabri ( Natalizumab ). The full Prescribing Information has been revised to add to the Warnings and P ...


Oral Terbinafine ( Lamisil ) is approved for the treatment of fungal infections of the nails and skin that are not responsive to topical therapy. ADRAC ( Adverse Drug Reactions Advisory Committee ) ...


Researchers have identified which variations of a specific gene determine a patient’s initial response to treatment with the anticoagulant drug Warfarin ( Coumadin ). Researchers found that the gene ...


Roche has informed HealthCare Professionals on recent update to the Tamiflu ( Oseltamivir ) package insert. The revisions to the product label are the result of recommendations made by the FDA Pedia ...


The FDA ( Food and Drug Administration ) is investigating a possible association between the use of Singulair ( Montelukast ) and behavior/mood changes, suicidality ( suicidal thinking and behavior ) ...


A study looked at the effects of taking a medication with anticholinergic properties on the annual change in thinking abilities of 870 Catholic nuns and clergy members who were an average of 75 years ...


Schizophrenia is a complex type of psychotic mental illness characterized by thoughts that are uncoupled from reality. Huge gains in the effective treatment of individuals with the disease began in th ...


Previous research on animal and physiological models suggest that antioxidant supplements have beneficial effects that may prolong life. Some observational studies also suggest that antioxidant supple ...


Amgen and Wyeth Pharmaceuticals have added a Boxed Warning to the Enbrel ( Etanercept ) US Prescribing Information to further strengthen and clarify information regarding the risk of infections, inclu ...


The CHMP, the scientific Committee of the European Medicines Agency ( EMEA ), adopted a negative opinion, recommending the refusal of the marketing authorisation for the medicinal product Ramelteon 4 ...


The FDA ( Food and Drug Administration ) has notified manufacturers of fluoroquinolone antimicrobial drugs that a Boxed Warning in the product labeling concerning the increased risk of tendinitis and ...


The FDA ( Food and Drug Administration ) has approved once-daily Seroquel XR ( Quetiapine fumarate ) Extended-Release Tablets for the acute treatment of the depressive episodes associated with bipolar ...


Patients treated for their prolonged seizures with the sedative Propofol ( Diprivan ) may be at high risk for complications and even death. New research showed that the use of Propofol as an antiep ...


On November 8, 2007, the Aranesp ( Darbepoetin alpha ) and Epogen / Procrit ( Epoetin alpha ) labeling were revised to describe the results of 6 studies showing increased mortality and more rapid tumo ...


The FDA ( Food and Drug Administration ) has approved additional changes to the Ortho Evra Contraceptive Transdermal Patch label to include the results of a new epidemiology study that found that user ...


The FDA ( Food and Drug Administration ) has approved Tysabri ( Natalizumab ) for the treatment of moderate-to-severe Crohn's disease in patients with evidence of inflammation who have had an inadequa ...


Bayer Schering Pharma AG and Genzyme Europe BV have informed Healthcare Professionals on six infection-related deaths, reported from a trial ( CALGB10101 ) in which previously untreated, symptomatic ...


Cephalon informed Healthcare Professionals of the following new warnings and safety information for Provigil ( Modafinil ) regarding serious skin rash and psychiatric symptoms which have been provided ...


In agreement with the EMEA, F.Hoffmann-La Roche informed Health Care Professionals of new safety information regarding CellCept ( Mycophenolate mofetil ). • Isolated cases of progressive multifoca ...


The FDA ( Food and Drug Administration ) has received information regarding a study that was performed to investigate the possibility of an increased risk of cancer in patients with diabetes who appl ...


The FDA ( Food and Drug Administration ) has been made aware of recent findings from analyses of data collected from " The Data Collection on Adverse Events of Anti-HIV Drugs ( D:A:D ) Study ". The ...


The FDA ( Food and Drug Adminsitration ) is investigating a possible association between the use of Singulair ( Montelukast ) and behavior/mood changes, suicidality ( suicidal thinking and behavior ) ...


GlaxoSmithKline has informed Healthcare Professionals of a recent update to the Relenza ( Xanamivir ) Inhalation Powder package insert. The revision to the product label is a result of information a ...


The Exubera label has been updated by Pfizer and FDA ( Food and Drug Administration ). The update resulted from Pfizer and FDA ’s safety reporting and review processes related to clinical trials pro ...


The FDA ( Food and Drug Administration ) has approved Amitiza ( Lubiprostone ) for the treatment of irritable bowel syndrome with constipation ( IBS-C ) in adult women aged 18 and over. There is cur ...


The FDA ( Food and Drug Administration ) has approved Relistor ( Methylnaltrexone bromide) to help restore bowel function in patients with late-stage, advanced illness who are receiving opioids on a c ...


The FDA ( Food and Drug Administration ) has approved a new drug for treating Crohn's disease. Cimzia ( Certolizumab pegol ) received approval for adults with moderate to severe Crohn's disease who ...


In Canada the use of intravenous immune globulin ( IVIG ) is reported to have increased by approximately 115% over the past 7-8 years, making Canada one of the highest per capita users of IVIG in the ...


Evra is a transdermal hormonal contraceptive system containing 6 mg of Norelgestromin and 0.6 mg of Ethinyl Estradiol per patch. Since its introduction on the Canadian market in early 2004, 16 cas ...


Topiramate ( Topamax ) is an antiepileptic indicated for either monotherapy or add-on therapy in adults and in children aged two years and over; and for the prophylaxis of migraine in adults. Topir ...


The FDA ( Food and Drug Administration ) has approved Entereg ( Alvimopan ) to accelerate the restoration of normal bowel function in patients 18 years and up who have undergone partial large or small ...


Aprotinin ( Trasylol ) is associated with a 50 per cent increase in the relative risk of death, according to a major Canadian clinical trial comparing three drugs routinely used to prevent blood loss ...


Access to Trasylol ( Aprotinin ) is limited to investigational use of the drug according to the procedures described in a special treatment protocol. The protocol allows treatment for certain patients ...


The FDA ( Food and Drug Administration ) has required manufacturers of conventional antipsychotic drugs to make safety-related changes to prescribing information, or labeling, to warn about an increas ...


Safety reviews of tumor necrosis factor-alpha ( TNF-a ) antagonists, Infliximab ( Remicade ), Etanercept ( Enbrel ), and Adalimumab ( Humira ) identified rare cases of serious skin reactions, includin ...


The FDA ( Food and drug Administration ) has informed healthcare professionals of the risk of adverse injection site reactions in patients receiving Naltrexone ( Vivitrol ). Physicians should instr ...


Since October 2007, FDA ( Food and Drug Administration ) has received reports of 6 cases of hemorrhagic or necrotizing pancreatitis in patients taking Byetta ( Exenatide ). Byetta is a medicine giv ...